OBSERVE MEDICAL ASA – Updated ticker code and ISIN for the subscription rights

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.

Reference is made to the stock exchange announcement published by Observe Medical ASA (the "Company") on 21 November 2023, with updated key information relating to the rights issue in the Company raising gross proceeds of up to NOK 55 million (the "Rights Issue").  

Updated key information relating to the ticker code and the ISIN for the subscription rights is set out below.

The subscription rights will be listed under ticker code "OBSRT"

ISIN for the subscription rights: ISIN NO0013076943

For further information about the Company, please contact:

Rune Nystad, CEO Observe Medical

Mobile: +47 916 24 683

E-mail: [email protected]

Per Arne Nygård, CFO Observe Medical

Mobile: +47 411 04 345

E-mail: [email protected]

This stock exchange announcement was published by Per Arne Nygård, CFO on 23 November 2023 at 07:55 (CET) on behalf of the Company.

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement, ultrasound, anesthesiology/ICUs, surgery and wound care, in combination with targeted M&A.

The Company is headquartered in Oslo, Norway, with additional offices in Narvik, Norway and Gothenburg, Sweden, and subsidiaries in Finland and the US. In addition, Observe Medical has a direct sale organization in the Nordics and a distributor network internationally.

Further information is available at www.observemedical.com.

***

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.